CAL Stock Analysis: Caleres | NYSE
Apparel Retail | NYSE, USA | Market Cap: 422m USD | 12M Return: -6.8% | US1295001044 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 6.12M
EPS Trend: -92.3%
Qual. Beats: 0
Rev. Trend: -21.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Caleres, Inc. is a U.S.-based footwear company that designs, develops, sources, manufactures, and distributes footwear across the United States, Canada, East and Southeast Asia, and other international markets. The company operates through two main segments: Famous Footwear and Brand Portfolio, distributing licensed, branded, and private-label athletic, casual, and dress footwear. It retails third-party brands such as Nike, Skechers, adidas, Crocs, Converse, Birkenstock, HeyDude, New Balance, Puma, Jordan, Vans, Bearpaw, Asics, and Brooks, while also marketing its own portfolio of owned and licensed labels, including Sam Edelman, Vionic, Allen Edmonds, Franco Sarto, Rykä, Vince, LifeStride, Dr. Scholls Shoes, Blowfish Malibu, and Naturalizer.
The business runs an omnichannel footwear model, combining retail shoe stores, wholesale distribution to department stores, mass merchandisers, national chains, and independent retailers, and direct-to-consumer e-commerce through a network of brand websites. The company was founded in 1878, is headquartered in Saint Louis, Missouri, and was formerly known as Brown Shoe Company before adopting the Caleres name in May 2015. As a small-cap consumer discretionary stock in the apparel retail sub-industry, Caleres is positioned in a sector that is highly sensitive to discretionary consumer spending and seasonal demand patterns, and it competes with both specialty footwear retailers and broader apparel and department store chains.
- Famous Footwear comparable sales lift consolidated revenue
- HeyDude brand growth accelerates wholesale and DTC channels
- Footwear tariff exposure pressures Asia sourcing costs
| Net Income: 52.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 4.45 > 1.0 |
| NWC/Revenue: 3.71% < 20% (prev 3.18%; Δ 0.53% < -1%) |
| CFO/TA 0.05 > 3% & CFO 117.3m > Net Income 52.5m |
| Net Debt (1.42b) to EBITDA (140.0m): 10.11 < 3 |
| Current Ratio: 1.11 > 1.5 & < 3 |
| Outstanding Shares: last quarter (32.6m) vs 12m ago 0.02% < -2% |
| Gross Margin: 46.25% > 18% (prev 43.97%; Δ 2.27% > 0.5%) |
| Asset Turnover: 132.8% > 50% (prev 123.3%; Δ 9.52% > 0%) |
| Interest Coverage Ratio: 3.83 > 6 (EBIT TTM 73.8m / Interest Expense TTM 19.2m) |
| A: 0.05 (Total Current Assets 1.05b - Total Current Liabilities 943.1m) / Total Assets 2.14b |
| B: 0.23 (Retained Earnings 486.2m / Total Assets 2.14b) |
| C: 0.03 (EBIT TTM 73.8m / Avg Total Assets 2.14b) |
| D: 0.46 (Book Value of Equity 673.6m / Total Liabilities 1.45b) |
| Altman-Z'' = 1.78 = BBB |
| DSRI: 1.02 (Receivables 156.5m/143.3m, Revenue 2.85b/2.65b) |
| GMI: 0.95 (GM 43.97% / 46.25%) |
| AQI: 1.06 (AQ_t 0.16 / AQ_t-1 0.15) |
| SGI: 1.07 (Revenue 2.85b / 2.65b) |
| TATA: -0.03 (NI 52.5m - CFO 117.3m) / TA 2.14b) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of October 11, 2026, the stock is trading at USD 12.09 with a total of 253,019 shares traded. Over the past week, the price has changed by -1.06%, over one month by +0.10%, over three months by +5.94% and over the past year by -6.80%.
Current recommended Stop Loss: 11.00 (which is 9% or 1.9 ATR below the current price).
Caleres has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CAL.
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 17 | 40.6% |
P/E Trailing = 7.9869
P/E Forward = 7.728
P/S = 0.1481
P/B = 0.6332
P/EG = 0.8213
Revenue TTM = 2.85b USD
EBIT TTM = 73.8m USD
EBITDA TTM = 140.0m USD
Long Term Debt = 466.1m USD (estimated: total debt 877.3m - short term 411.2m)
Short Term Debt = 411.2m USD (from shortTermDebt, last quarter)
Debt = 1.47b USD (from shortLongTermDebtTotal, last quarter) + Leases 589.3m
Net Debt = 1.42b USD (calculated: Debt 1.47b - CCE 50.9m)
Enterprise Value = 1.84b USD (421.7m + Debt 1.47b - CCE 50.9m)
Interest Coverage Ratio = 3.83 (Ebit TTM 73.8m / Interest Expense TTM 19.2m)
EV/FCF = 29.71x (Enterprise Value 1.84b / FCF TTM 61.8m)
FCF Yield = 3.37% (FCF TTM 61.8m / Enterprise Value 1.84b)
FCF Margin = 2.17% (FCF TTM 61.8m / Revenue TTM 2.85b)
Net Margin = 1.84% (Net Income TTM 52.5m / Revenue TTM 2.85b)
Gross Margin = 46.25% ((Revenue TTM 2.85b - Cost of Revenue TTM 1.53b) / Revenue TTM)
Gross Margin QoQ = 54.78% (prev 47.33%)
Tobins Q-Ratio = 0.86 (Enterprise Value 1.84b / Total Assets 2.14b)
Interest Expense / Debt = 1.31% (Interest Expense 19.2m / Debt 1.47b)
Taxrate = 29.77% (21.3m / 71.6m)
NOPAT = 51.8m (EBIT 73.8m * (1 - 29.77%))
Current Ratio = 1.11 (Total Current Assets 1.05b / Total Current Liabilities 943.1m)
Debt / Equity = 2.18 (Debt 1.47b / totalStockholderEquity, last quarter 673.6m)
Debt / EBITDA = 10.11 (Net Debt 1.42b / EBITDA 140.0m)
Debt / FCF = 22.89 (Net Debt 1.42b / FCF TTM 61.8m)
Total Stockholder Equity = 626.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.45% (Net Income 52.5m / Total Assets 2.14b)
RoE = 8.38% (Net Income TTM 52.5m / Total Stockholder Equity 626.1m)
RoCE = 6.75% (EBIT 73.8m / Capital Employed (Equity 626.1m + L.T.Debt 466.1m))
RoIC = 3.33% (NOPAT 51.8m / Invested Capital 1.55b)
WACC = 3.38% (E(421.7m)/V(1.89b) * Re(11.92%) + D(1.47b)/V(1.89b) * Rd(1.31%) * (1-Tc(0.30)))
Discount Rate = 11.92% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -80.19 | Cagr: -1.66%
[DCF] Terminal Value 75.44% ; FCFF base≈61.8m ; Y1≈62.1m ; Y5≈65.8m
[DCF] Fair Price = N/A (negative equity: EV 1.02b - Net Debt 1.42b = -392.5m; debt exceeds intrinsic value)
EPS Correlation: -92.29 | EPS CAGR: -46.09% | SUE: 0.39 | # QB: 0
Revenue Correlation: -20.95 | Revenue CAGR: -0.53% | SUE: -0.39 | # QB: 0
EPS current Quarter (2026-10-31): EPS=0.65 | Chg30d=-22.23% | Revisions=-25% | Analysts=3
EPS current Year (2027-01-31): EPS=1.61 | Chg30d=-1.23% | Revisions=+50% | GrowthEPS=+35.0% | GrowthRev=+3.9%
EPS next Year (2028-01-31): EPS=2.19 | Chg30d=-3.66% | Revisions=-50% | GrowthEPS=+36.5% | GrowthRev=+2.8%
[Analyst] Revisions Ratio: -10% (up=3, down=4)